Smart Mind Maps in Promoting Safe Administration of High-Alert Medications

In PICU setting, drug administration, monitoring, and prescribing errors made up most cases (54%) of MEs . Emphasizes these issues requires a multifaceted approach, including staff training, creation of innovative cognitive frameworks, use of electronic prescribing systems, and the promotion of a safety-awareness within healthcare settings. Recently, mind mapping has been applied in the field of nursing education as an advanced conceptual tool. It uses a technique of combining drawings with words to build memory associations between a topic keyword and image, color, or other link allowing learners to effectively store and extract information

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

PICU Nurses

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study aims to evaluate the effectiveness of smart mind maps in promoting safe administration of high-alert medications among nurses in the pediatric intensive care unit. Designing a mind map using AI holds significant value for nurses working in the PICU. AI-powered mind maps can help nurses organize complex patient information more efficiently, enabling quicker decision-making and improved care planning. By integrating AI, the mind map can automatically update with real-time data, alert nurses to critical changes, and even suggest evidence-based interventions. This not only enhances patient safety and care quality but also reduces cognitive load and streamlines communication among the healthcare team .

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Nurses on duty in the PICU (who directly handled HAM) irrespectively to their age, sex, educational level.

Exclusion criteria

Nurses who do not handle with HAM

Treatment and study plan

smart mind mapsde

Other

designing a smart mind maps as an advanced conceptual tool to help nurses understand well about HAMs

Primary outcomes

Tool I: A Structured Assessment Questionnaire

Time frame: 2 weeks

It will be developed by the researcher which will consist of two parts:

Part 1: Socio-demographic Characteristics and Professional Data of Studied Nurses part 2: Knowledge Assessment Tool on AI and Mind Mapping for Nurses (pre/posttest)
Tool II: Nurses' Knowledge Regarding Safe Use of High-Alert Medications (HAMs)

Time frame: 1 month

It will be developed to collect data necessary for evaluating nurses' knowledge related to safe use of high-alert medications. The assessment will encompass key domains such as the definition and classification of HAMs, safety precautions during drug administration (including delivery routes and dosage accuracy), and drug regulation (including proper storage, documentation, and handling procedures).
Tool III: Observational Checklist for Safe Handling of High Alert Medications

Time frame: 2 month

It will be developed by the researcherto objectively assess nurses' practices related to the safe handling of high-alert medications in PICUs according to the international recognized guidelines and evidence-based protocols.

Study contacts

Contact information is provided by the study sponsor or research team.

doaa osman ibrahim doaa ibrahim- assistant lecturer, assistant lecturer

CONTACT

[email protected]

020-01069637084

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

The Effectiveness of Smart Mind Maps in Promoting Safe Administration of High-Alert Medications Among Nurses in the Pediatric Intensive Care Unit

Acronym: HAMs- PICU

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Jan 6, 2026
Registry last updated: Jan 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting